Tumor Suppressive Role of MicroRNAs in Triple Negative Breast Cancer

Curr Pharm Des. 2023;29(42):3357-3367. doi: 10.2174/0113816128272489231124095922.

Abstract

Triple-negative breast cancers are highly aggressive, a heterogeneous form of breast cancer with a high re-occurrence rate that further lacks an efficient treatment strategy and prognostic marker. The tumor microenvironment of the disease comprises cancer-associated fibroblasts, cancer stem cells, immunological molecules, epithelial-mesenchymal transition, and a metastatic microenvironment that contributes to disease progression and metastasis to distant sites. Emerging evidence indicated that miRNA clusters would be of clinical utility as they exert an oncogenic or tumor suppressor role in TNBC. The present review article aims to highlight the therapeutic significance of miRNA in targeting the above-mentioned signaling cascades and modulating the intracellular crosstalk in the tumor microenvironment of TNBC. Prognostic implications of miRNAs to depict disease-free survival, distant metastasis-free survival, relapse-free survival, and overall survival outcome were also unveiled.

Keywords: CAFs; CSCs; EMT; TME; TNBC; miRNAs; prognosis; therapeutic..

Publication types

  • Review

MeSH terms

  • Cell Line, Tumor
  • Disease Progression
  • Epithelial-Mesenchymal Transition / genetics
  • Female
  • Humans
  • MicroRNAs* / genetics
  • Neoplasm Recurrence, Local
  • Prognosis
  • Triple Negative Breast Neoplasms* / genetics
  • Tumor Microenvironment

Substances

  • MicroRNAs